Natalia McInnes

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Disease Activity

Rheumatoid Arthritis

Top Venues

Diabetes, obesity & metabolism

JCEM case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Brian Lauzon, Tala Abu-Hijleh, Natalia McInnes, Ally Prebtani
Hematologic Malignancies: Two Cases of a Rare Cause of Hypopituitarism. JCEM case reports 2 (9) (2024)
Chang Ye, Jiajie Pu, Chang Ye, Alexandra Emery, Stewart B Harris, Sonja M Reichert, Ulagamadesan Venkatesan, Natalia McInnes, Caroline Kaercher Kramer, Bernard Zinman
A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity. Diabetes care (2024)
Zubin Punthakee, Stephanie Hall, Natalia McInnes, Diana Sherifali, Kate Tsiplova, Faith R Kirabo, Thomas P P Ransom, Stewart B Harris, Heather A Lochnan, Ronald J Sigal, Mahua Ghosh, Tamara Spaic, Ulagamadesan Venkatesan, null null
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial. Diabetes, obesity & metabolism (2024)
Natalia McInnes, Stephanie Hall, Heather A Lochnan, Stewart B Harris, Zubin Punthakee, Ronald J Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne F Liutkus, Jean-François Yale, Farah Sultan, Ada Smith, Rose E Otto, Diana Sherifali, Yan Yun Liu, Ulagamadesan Venkatesan, null null
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes, obesity & metabolism (2023)
Natalia McInnes, Stephanie Hall, Irene Hramiak, Ronald J Sigal, Ronald M Goldenberg, Nikhil Gupta, Remi Rabasa-Lhoret, Manoela Braga, Vincent Woo, Farah Sultan, Rose Otto, Ada Smith, Diana Sherifali, Yan Yun Liu, Ulagamadesan Venkatesan, null null, null null
Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial. Diabetes care (2021)